Logo-jcvtr

J Cardiovasc Thorac Res. 2024;16(2): 113-119. doi: 10.34172/jcvtr.33103

Original Article

Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial

Hossein Behzad 1 ORCID, Sina Mashayekhi 2, Hila Asham 1, Parvin Sarbakhsh 3, Taher Entezari-Maleki 1,2 * ORCID

Cited by CrossRef: